Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-18

Clinical Trial Update: Effect of Gymnema Sylvestre on Patients With Impaired Glucose Tolerance. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Gymnema Sylvestre for impaired glucose tolerance has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gymnema sylvestre (Gymnema sylvestre)

Snippet

Sponsor: University of Guadalajara | Conditions: Impaired Glucose Tolerance | Phase 2 | Status: COMPLETED | Results posted: 2020-11-18